Beijing may be about to approve the use of the messenger ribonucleic acid (mRNA) vaccine from BioNTech “very soon,” the German drugmaker’s distributor for the Greater China Region has revealed. Shanghai Fosun Pharma has teased its shareholders and foreigners in China that the mRNA vaccine could be on course for a roll-out in a month […]
Thank you for registering!
An account was already registered with this email. Please check your inbox for an authentication link.
